Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2013 Feb;6(2):119-28.
doi: 10.1158/1940-6207.CAPR-12-0281. Epub 2012 Dec 11.

Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability

Affiliations
Clinical Trial

Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability

Glen R B Irving et al. Cancer Prev Res (Phila). 2013 Feb.

Abstract

Curcumin, the main constituent of turmeric, is suspected to possess cancer chemopreventive properties. Pharmacokinetic and pharmacodynamic parameters have been reported, but few data exist describing whether methodologies are suitably robust for curcuminoid detection in colonic biopsy specimens. Information on the acceptability of prolonged administration of daily curcumin is not available. This is of vital importance to implement chemoprevention strategies. This study aimed to quantify levels of curcuminoids in colorectal mucosa of patients undergoing colorectal endoscopy or surgical resection and to obtain information on the acceptability and compliance with daily curcumin. Curcumin C3 complex (2.35 g) was administered to patients once daily for 14 days before endoscopic biopsy or colonic resection. Safety and tolerance were monitored. Analysis of curcuminoids in plasma, urine, and colonic mucosa was conducted by ultraperformance liquid chromatography (UPLC)-UV with characterization by liquid chromatography/tandem mass spectrometry (LC/MS-MS). Twenty-four of 26 patients commencing curcumin completed the course. Six patients reported mild gastrointestinal adverse events. Curcuminoids were detectable in nine of 24 plasma samples, 24 of 24 urine samples, and in the colonic mucosa of all 23 biopsied participants. Mean tissue levels were 48.4 μg/g (127.8 nmol/g) of parent curcuminoids. The major conjugate, curcumin glucuronide, was detectable in 29 of 35 biopsies. High levels of topical curcumin persisted in the mucosa for up to 40 hours postadministration. Sixteen participants (67%) stated that they would take curcumin long-term should it be of proven benefit. In summary, pharmacologically active levels of curcumin were recovered from colonic mucosa. The regimen used here seems safe, and patients support its use in long-term trials.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Consolidated Standards of Reporting Trials (CONSORT) chart for this study.
Figure 2
Figure 2
UPLC-UV chromatography of (a) standards of C3-complex curcumin, biosynthetic curcumin glucuronides, chemically synthesised curcumin sulphates and control solvent, and (b) extracts of colonic mucosa, plasma and urine from patients who had received oral C3-complex curcumin (2.35 g daily for 14 days) and plasma and urine from individuals who had yet to receive the agent (control biomatrix). Plasma and tissue bio-matrices were obtained approximately 24 h after the final dose of curcumin. Urine was collected continuously for the 24 h between the last two doses. (c) LC-MS/MS of curcuminoids present in curcumin and metabolite standards obtained in selected reaction monitoring (SRM) mode with the m/z transitions for each analyte in brackets.
Figure 2
Figure 2
UPLC-UV chromatography of (a) standards of C3-complex curcumin, biosynthetic curcumin glucuronides, chemically synthesised curcumin sulphates and control solvent, and (b) extracts of colonic mucosa, plasma and urine from patients who had received oral C3-complex curcumin (2.35 g daily for 14 days) and plasma and urine from individuals who had yet to receive the agent (control biomatrix). Plasma and tissue bio-matrices were obtained approximately 24 h after the final dose of curcumin. Urine was collected continuously for the 24 h between the last two doses. (c) LC-MS/MS of curcuminoids present in curcumin and metabolite standards obtained in selected reaction monitoring (SRM) mode with the m/z transitions for each analyte in brackets.
Figure 3
Figure 3
(a) Mean curcumin (expressed as μg/g of tissue) present in consecutive washes from 1 right-sided, 4 left-sided, 6 sigmoidoscopy, 12 paired right-sided and 12 paired left-sided biopsy samples. Black bars show mean data from each wash cycle. White bar shows mean cumulative curcumin removed during wash cycles (n=35), ± SEM. (b) UPLC-UV chromatography of extracts from serial washes (using 1.15% KCl) performed on colonic mucosa to remove surface C3-complex curcumin. Up to seven consecutive washes were performed until excess surface curcumin had been removed and surface levels were at a steady state.

References

    1. Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, et al. Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia. Cancer Prev Res (Phila) 2011;4(3):354–64. - PMC - PubMed
    1. Sugawara J, Akazawa N, Miyaki A, Choi Y, Tanabe Y, Imai T, et al. Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study. American journal of hypertension. 2012;25(6):651–6. - PubMed
    1. Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. 2008;28(1):110–3. - PubMed
    1. Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. The British journal of nutrition. 2010;103(11):1545–57. - PubMed
    1. Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? The AAPS journal. 2009;11(3):495–510. - PMC - PubMed

Publication types

MeSH terms